These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31004034)

  • 41. Role of chromogenic assays in haemophilia A and B diagnosis.
    Bowyer AE; Duncan EM; Antovic JP
    Haemophilia; 2018 Jul; 24(4):578-583. PubMed ID: 29808946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular diagnosis in patients and carriers of hemophilia A and B].
    Mantilla-Capacho J; Beltrán-Miranda CP; Jaloma-Cruz AR
    Gac Med Mex; 2005; 141(1):69-71. PubMed ID: 15754755
    [No Abstract]   [Full Text] [Related]  

  • 43. Environmental and genetic factors influencing inhibitor development.
    Oldenburg J; Schröder J; Brackmann HH; Müller-Reible C; Schwaab R; Tuddenham E
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):82-8. PubMed ID: 14872427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of ten novel mutations in factor VIII gene: A study of a cohort of 52 haemophilia A patients.
    Santacroce R; Leccese A; Trunzo R; Lassandro G; Giordano P; Ettorre C; Antoncecchi S; Cantori I; Dragani A; Belvini D; Salviato R; Margaglione M
    Thromb Res; 2015 May; 135(5):1031-4. PubMed ID: 25628142
    [No Abstract]   [Full Text] [Related]  

  • 45. [Genetic factors in hemophilia].
    Rozynkowa D
    Acta Haematol Pol; 1987; 18(1-2):96-100. PubMed ID: 3124485
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics of VWF/FVIII concentrates is a very intricate matter.
    Morfini M
    Haemophilia; 2011 Nov; 17(6):846-8. PubMed ID: 22029760
    [No Abstract]   [Full Text] [Related]  

  • 47. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity.
    Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe female hemophilia A patient caused by a nonsense mutation (p.Gln1686X) of F8 gene combined with skewed X-chromosome inactivation.
    Zheng J; Ma W; Xie B; Zhu M; Zhang C; Li J; Wang Y; Wang M; Jin Y
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):977-8. PubMed ID: 26517067
    [No Abstract]   [Full Text] [Related]  

  • 49. Gene symbol: f9.
    Niceta M; Carmelo F; Pietro S; Fabio G; Giacomo M
    Hum Genet; 2007 Apr; 121(2):297. PubMed ID: 17598222
    [No Abstract]   [Full Text] [Related]  

  • 50. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of the prevalence of clotting factor deficiency in carriers of haemophilia A and haemophilia B.
    Boban A; Lambert C; Lannoy N; Hermans C
    Haemophilia; 2017 Sep; 23(5):e471-e473. PubMed ID: 28689376
    [No Abstract]   [Full Text] [Related]  

  • 52. The molecular basis of severe hemophilia B in a girl.
    Nisen P; Stamberg J; Ehrenpreis R; Velasco S; Shende A; Engelberg J; Karayalcin G; Waber L
    N Engl J Med; 1986 Oct; 315(18):1139-42. PubMed ID: 3093864
    [No Abstract]   [Full Text] [Related]  

  • 53. Fluorescent PCR-based gene dose analysis for detection of deletion mutations in carriers of haemophilia.
    Devi GS; Arora N; Rajkumar SV; Edison ES; Srivastava A; Jayandharan GR
    Haemophilia; 2013 Nov; 19(6):e377-80. PubMed ID: 23855319
    [No Abstract]   [Full Text] [Related]  

  • 54. A golden age for Haemophilia treatment?
    Makris M; Hermans C
    Haemophilia; 2018 Mar; 24(2):175-176. PubMed ID: 29601683
    [No Abstract]   [Full Text] [Related]  

  • 55. The molecular basis of haemophilia A and B.
    Giannelli F; Green PM
    Baillieres Clin Haematol; 1996 Jun; 9(2):211-28. PubMed ID: 8800501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemophilia A and B: molecular and clinical similarities and differences.
    Castaman G; Matino D
    Haematologica; 2019 Sep; 104(9):1702-1709. PubMed ID: 31399527
    [No Abstract]   [Full Text] [Related]  

  • 57. Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica.
    Salazar-Sánchez L; Jiménez-Cruz G; Chaverri P; Schröder W; Wulff K; Jiménez-Arce G; Sandoval M; Ramírez P; Herrmann FH
    Rev Biol Trop; 2004 Sep; 52(3):521-30. PubMed ID: 17361545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular basis of hemophilia.
    Furie B; Furie BC
    Semin Hematol; 1990 Jul; 27(3):270-85. PubMed ID: 2115693
    [No Abstract]   [Full Text] [Related]  

  • 59. Molecular biology of the hemophilias.
    Thompson AR
    Prog Hemost Thromb; 1991; 10():175-214. PubMed ID: 1901173
    [No Abstract]   [Full Text] [Related]  

  • 60. The hemophilias.
    Green PM; Naylor JA; Giannelli F
    Adv Genet; 1995; 32():99-139. PubMed ID: 7741026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.